Johnson & Johnson reportedly has received initial takeover bids for its Ortho Clinical Diagnostics division from private equity groups including KKR, Bain Capital, BC Partners, Carlyle Group and Blackstone Group. Sources say the diagnostics business, which focuses on laboratory blood tests and blood screening tools, could pull in about $5 billion.

Full Story:

Related Summaries